US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3500
  • -0.0100-0.74%
Close Jul 19 16:00 ET
  • 1.3700
  • +0.0200+1.48%
Post 19:57 ET
282.96MMarket Cap-6136P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

32.61M

-18.49%
EPS(YoY)

-0.09

+40.00%
Analyst Rating

Buy

Jul 12, 2024

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 44.712M--
--2024/Q2-- / 49.452M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 44.712M--
--2024/Q2-- / 49.452M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

  • Akebia Therapeutics | 10-Q: Quarterly report

    May 9 07:07 ET

  • Akebia Therapeutics | 10-K: Annual report

    Mar 14 17:21 ET

  • Akebia Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 07:45 ET

  • Akebia Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 28, 2023 08:57 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg